Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling
| dc.creator | Basha, Shaik Lahoor | |
| dc.creator | Suresh, Sake | |
| dc.creator | Ashok Reddy, V.V. | |
| dc.creator | Surya Teja, S.P. | |
| dc.date.accessioned | 2020-11-04T15:51:17Z | |
| dc.date.available | 2020-11-04T15:51:17Z | |
| dc.date.created | 2020 | |
| dc.description.abstract | Despite being announced as a global health concern and emergency in January by WHO, designing specific treatment for SARS-CoV-2 is still a summit yet to be conquered. Currently, many drugs are being tested in the clinical scenario and vitamins play a significant role in therapeutic management. Based on the available evidence, we postulate that maintaining normal vitamin D3 levels may reduce severity, mortality risk of COVID-19. This review elucidates the alarming need for randomized clinical trials to determine the role of vitamin D in patient prognosis in COVID-19 infection and on latitude bases epidemiological outcome. | spa |
| dc.format.extent | 28 páginas | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.doi | https://doi.org/10.1016/j.cegh.2020.10.005 | spa |
| dc.identifier.issn | 2213-3984 | spa |
| dc.identifier.other | https://doi.org/10.1016/j.cegh.2020.10.005 | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12010/15313 | |
| dc.language.iso | eng | spa |
| dc.publisher | Clinical Epidemiology and Global Health | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.local | Abierto (Texto Completo) | spa |
| dc.source | reponame:Expeditio Repositorio Institucional UJTL | spa |
| dc.source | instname:Universidad de Bogotá Jorge Tadeo Lozano | spa |
| dc.subject | Cathelicidin | spa |
| dc.subject | Latitude | spa |
| dc.subject | Influenza | spa |
| dc.subject | Pneumonia | spa |
| dc.subject | Diabetes | spa |
| dc.subject | Hypertension | spa |
| dc.subject.lemb | Síndrome respiratorio agudo grave | spa |
| dc.subject.lemb | COVID-19 | spa |
| dc.subject.lemb | SARS-CoV-2 | spa |
| dc.subject.lemb | Coronavirus | spa |
| dc.title | Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | spa |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
| dc.type.local | Artículo | spa |
Archivos
Bloque de licencias
1 - 1 de 1
Cargando...
- Nombre:
- license.txt
- Tamaño:
- 2.87 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción:
